Magnolia’s Post

Estimates suggest that ~350m people live with #rarediseases globally. On #RareDiseaseDay find out why it’s not so rare to have a #raredisease and how we can innovate to overcome the challenges of developing new treatments at https://bit.ly/3kkFQUE. #clinicaltrials #biotech #pharma #biopharma #orphandisease #orphandiseases

Why do drug developers turn to Sanquin PBS when faced with demanding cells? Just because a cell is delicate to work with doesn’t mean that it should be excluded from quality, safety, or efficacy controls during drug development. Through its vast experience and an optimized workflow, Sanquin PBS can study all phenotypic and functional aspects of difficult-to-handle blood cells including phagocytosis, degranulation, NETosis, migration, cytokine release, and apoptosis.  Read more in our blood story: Why do clients turn to Sanquin PBS when faced with difficult cells? - https://lnkd.in/eMdQ7qWG #drugdevelopment #pharma #biotech #bioanalysis #immunomonitoring 

Dr Arie Belldegrun, Allogene Therapeutics, will provide a keynote presentation on "Pushing the Boundaries of Investments and Adapting to the IO Market Dynamics" at the 11th Annual IO360º Summit. View the agenda and learn more at io360summit.com #IO360Summit #immunooncology #Pharma #Biotech #Conference

🧬💊 Discover some common misconceptions about the pharma and biotech industry that might surprise you! 🤝  In my conversations, I realise that many people outside our industry still hold misconceptions. So, I’ve put together a collection of the most popular ones. 📜 Download a free slide deck to uncover the truth. If you want Part 2, please let me know by commenting on this post. I will then send you a pdf. #Biotech #Pharma #IndustryInsights #MythBusting #CDMO #misconceptions

We all know the importance of Sample Management. Why not join #Avantor next week at our 4th EU Sample Management Symposium?! See below for more details and the links to register - see you there !! #Pharma #biotech #Avantorsetsscienceinmotion #SLAS2024

Time and money are precious—save both with MAbSilico! 💰 Skip the back-and-forth optimization of hits and start immediately with lead candidates ready for development. Maximize efficiency and minimize costs in your antibody discovery journey. 🌐 mabsilico.com #DrugDesign #DrugDiscovery #BioTechs #Pharma #Insilico

We're getting questions on what BioCentury Inc. is hearing about the Biosecure Act (and similar bills), which could restrict U.S. biopharma access to Chinese CDMOs (e.g., WuXi AppTec, WuXi Biologics) and genomics companies. For those looking for answers, we have posted two (free) resources to check out: ➢ BioCentury industry survey results (March 21) on the likely impact of the bills on drug development and U.S. biotech: https://lnkd.in/ddBzRwNi ➢ Discussion of the survey results on the BioCentury This Week podcast (March 25), including commentary from my colleagues Simone Fishburn, Steve Usdin and Jeff Cranmer: https://lnkd.in/dxHyp96n We will post more, as we hear more. Bookmark this Hot Topics page for future posts: https://lnkd.in/denr92vJ #drugdevelopment #biopharma #biotech #pharma

Elevating the art of lead identification! 🚀 Explore the journey from affinity-driven binding to predetermined epitopes using AI-based tools. MAbSilico's strategic approach ensures the design of antibodies that not only meet but exceed expectations in triggering desired biological effects and achieving high efficacy. 🌐 mabsilico.com #BioTechs #Pharma #Insilico

Thoughts on this? >> Lyell Immunopharma to acquire ImmPACT Bio, cut top programs >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #productmarketing #pharma #biotech #healthcare #pharmaceutical

Looking forward presenting in 2 weeks, for the first time externally, our work on shipments with clinical samples, their carbon footprint, and how we can reduce (and get savings along!)... The title of that Symposium is "Challenges and Solutions of Sample Management": I believe that a challenge (to come) is how we will operate by 2030 in a context of targeted carbon-neutrality (scopes 1, 2 & 3). I will present there one solution we built, which will help a lot in that direction - among others! #environmental #sustainability #shipments #clinical #samples #Novartis